- Home
- NRT vs DTIL Comparison
NRT vs DTIL Comparison
Compare NRT & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRT
- DTIL
- Stock Information
- Founded
- NRT 1975
- DTIL 2006
- Country
- NRT United States
- DTIL United States
- Employees
- NRT N/A
- DTIL N/A
- Industry
- NRT Oil & Gas Production
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- NRT Energy
- DTIL Health Care
- Exchange
- NRT Nasdaq
- DTIL Nasdaq
- Market Cap
- NRT 44.0M
- DTIL 51.6M
- IPO Year
- NRT N/A
- DTIL 2019
- Fundamental
- Price
- NRT $5.18
- DTIL $4.79
- Analyst Decision
- NRT
- DTIL Strong Buy
- Analyst Count
- NRT 0
- DTIL 2
- Target Price
- NRT N/A
- DTIL $47.00
- AVG Volume (30 Days)
- NRT 37.1K
- DTIL 85.2K
- Earning Date
- NRT 05-30-2025
- DTIL 07-31-2025
- Dividend Yield
- NRT 9.07%
- DTIL N/A
- EPS Growth
- NRT 24.05
- DTIL N/A
- EPS
- NRT 0.59
- DTIL N/A
- Revenue
- NRT $6,184,173.00
- DTIL $51,141,000.00
- Revenue This Year
- NRT N/A
- DTIL N/A
- Revenue Next Year
- NRT N/A
- DTIL $30.20
- P/E Ratio
- NRT $8.83
- DTIL N/A
- Revenue Growth
- NRT 18.55
- DTIL N/A
- 52 Week Low
- NRT $3.88
- DTIL $3.61
- 52 Week High
- NRT $6.90
- DTIL $11.09
- Technical
- Relative Strength Index (RSI)
- NRT 57.49
- DTIL 44.86
- Support Level
- NRT $5.05
- DTIL $4.20
- Resistance Level
- NRT $5.45
- DTIL $5.29
- Average True Range (ATR)
- NRT 0.20
- DTIL 0.36
- MACD
- NRT -0.01
- DTIL -0.03
- Stochastic Oscillator
- NRT 52.24
- DTIL 36.88
About NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.